MarketPulse — Real-Time Financial News & Market Analysis

Trump administration pursues alternative tariff strategies after Supreme Court ruling limits executive power, implementing duties under different legal provisions while economic growth slows and inflation persists.

Nalanda Fund adds $43.9M to Genpact stake despite stock's 27% decline. Institutional confidence suggests undervalued opportunity amid AI disruption concerns.

Tech stock pullbacks have created buying opportunities in companies like TSMC, Nvidia, and Microsoft, which maintain strong fundamentals despite recent price declines.

Eupraxia Pharmaceuticals raises $63.2M to advance its GI disease pipeline, including EP-104GI trials for eosinophilic esophagitis and other gastrointestinal indications.

Oracle stock dropped 5% after Nvidia cut its OpenAI investment commitment from $100B to $30B, raising concerns about OpenAI's funding and Oracle's $300B infrastructure deal viability.

Enphase Energy faces securities fraud lawsuit alleging false statements about inventory management and credit exposure preparedness, affecting investors from April-October 2025.

REGENXBIO faces securities fraud lawsuit over alleged misrepresentations about RGX-111's safety and efficacy. A CNS tumor discovery contradicted prior investor statements, causing shareholder losses.

Schall Law Firm filed a securities class action against Kyndryl for allegedly making false financial disclosures and failing to maintain proper internal controls between August 2024 and February 2026.

Law firm investigates Gemini Space Station after three senior executives abruptly resigned, causing stock to plummet 12.83%. Seeking shareholders for potential class action lawsuit.

Securities fraud lawsuit filed against uniQure for allegedly making false statements about FDA approval processes and BLA submission timelines, causing investor losses.

Law firm investigates GRAIL for potential securities violations after cancer trial failure triggered stock decline. Examining whether company adequately disclosed trial risks.

PayPal faces class action lawsuit alleging false statements about Branded Checkout growth prospects. Investors who purchased securities Feb 2025-Feb 2026 invited to join litigation.

Schall Law Firm sues Paysafe Limited for securities fraud, alleging false statements about merchant risk exposure and understated credit losses between March-November 2025.

FDA accepts Teva's application for monthly olanzapine injection treating schizophrenia. The formulation eliminates post-injection monitoring requirements while maintaining efficacy.

Tesla shifts focus to humanoid robotics as EV sales slow, doubling capital spending to $20 billion and converting factories for robot production amid elevated valuation risks.

Remitly shares surge 30% on strong Q4 earnings and bullish 2026 outlook, with 26% revenue growth and record operating margins signaling sustained expansion.

Cannabis REIT IIPR faces revenue decline and unsustainable 111% dividend payout ratio, though potential federal cannabis reclassification and portfolio diversification could provide future upside.

Deere exceeded Q1 expectations and raised 2026 guidance, prompting analysts to boost price targets. Strong construction and agriculture divisions offset tariff margin pressures.

CoreWeave shares fell after reports of Blue Owl Capital's data center financing struggles. Both companies denied funding shortfalls, but the market reaction highlights investor concerns about AI infrastructure financing.

Plug Power faces securities fraud lawsuit alleging false statements about DOE loan funding and hydrogen projects. Lead plaintiff deadline: April 3, 2026.